Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-02-22
2005-02-22
Tsang, Cecilia J. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S327000, C514S329000, C514S330000, C546S192000, C546S216000, C546S223000, C546S224000, C546S228000
Reexamination Certificate
active
06858628
ABSTRACT:
The invention provides compounds which are useful as inhibitors of metalloproteases, and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the present invention relates to a compound having a structure according to Formula (I).Also disclosed are compounds, pharmaceutical compositions and methods of treating diseases characterized by metalloprotease activity using these compounds or the pharmaceutical compositions containing them.
REFERENCES:
patent: 4954158 (1990-09-01), Stammer
patent: 5455258 (1995-10-01), MacPherson et al.
patent: 769498 (1997-04-01), None
patent: WO 8802627 (1988-04-01), None
patent: WO 9633172 (1996-10-01), None
patent: WO 9720824 (1997-06-01), None
patent: WO 9724349 (1997-07-01), None
patent: WO 9725315 (1997-07-01), None
Bonnet et al., CA 63:11477b, 1965.
Shiba et al., CA 61:16145a, 1964.
Isenberg et al., CA 59:11932o, 1963.
Andreatta et al., CA 67:117254, 1967.
Lash et al., CA 116:41240, 1992.
Setoi et al., CA 111:1339B2, 1989.
Andreatta et al., CA 68:118364, 1968.
Philip et al., CA 87:102614, 1977.
Hudson et al., CA 68:87526, 1969.
Weber et al., CA 110:67646, 1989.
Kaspersen et al., CA 83:193215, 1975.
Krapcho et al., CA 96:181622, 1982.
Hudson et al., CA 84:69972, 1976.
Yevich et al., CA: 114:247309, 1991.
Goli et al., CA 122:133587, 1995.
Braish et al., CA 114:247308, 1991.
Jordis et al., CA 114:143341, 1991.
Rëmuzon et al., CA 120:164828, 1994.
Roemmele et al., CA 110:173729, 1989.
Kahl et al., CA 95:204385, 1981.
Wakamiya et al., CA 95:43606, 1981.
Shono et al., CA 101:151196, 1984.
Tronchet et al., CA 98:16975, 1983.
Koksharova et al., CA 97:18747, 1982.
Artico et al., CA 122:314404, Mar. 1995.
Matsubara et al., CA 121:275875, 1994.
Morimoto et al., CA 121:157461, 1994.
Hassan et al., CA 118:213398, 1993.
Di Cesare et al., CA 117:233883, 1992.
Wolski et al., CA 109:121786, 1988.
Belatter et al., CA 106:219573, 1987. K.
Shomo et al., CA 99:87977, 1983.
Ondetti et al., CA 94:175557, 1981.
Henry et al., CA 84:31125, 1976.
Kahl. J.U. et al., Synthesis of Two Naturally Occurring Diastereometic Dihydroxyprolines: 2,3-trans-3,4-tras-3,4-dihydroxy-L-prolin and 2,3-cis-3,4-tras-3,4-dihydorxy-L-proline:,Liebigs An. Chem., 1981, pp. 1445-1450.
Hudson, C.B. et al., “Synthesis of 3,4-dihydroxyprolines. I. Clsglycolation of 3,4-dehydroproline Derivatives”,Aust. J. Chem., 1988, vol. 21, pp. 769-782.
Andreatta, R.H. et al., “Synthesis of cis and trans Isomers of 4-chloro-L-proline, 4-bromo-L-proline, and 4-amino-L-Proline”,Aust. J. Chem., 1967, vol. 20, pp. 1493-1509.
Heintzelman, G.R. et al., “Imino Diels-Alder-Based Construction of a Piperidine A-Ring Unit for Total Synthesis of the Marine Hepatotoxin Cylindrospermopsin”,Chemical Abstracts, Jul. 29, 1986, vol. 125, No. 5, Abstract No. 058826.
Herdeis, C. et al., “Amino acids. XII. (.+−.)-Pipecolic acid derivatives. Part 2. An expedient synthetic entry to substituted pipecolic acids”,Chemical Abstracts, Oct. 26, 1992, vol. 117, No. 17, Abstract No. 171989.
Edwards, M.L. et al., “Synthesis and enzymic resolution of a carbocyclic analog of ribofuranosylamine”, Chemical Abstracts, Jul. 1, 1995, vol. 125, No. 1, Abstract No. 011281.
Almstead Neil Gregory
Bookland Roger Gunnard
Cheng Menyan
De Biswanath
Natchus Michael George
Covington Raymond
Paul Andrew A.
The Proctor & Gamble Company
Tsang Cecilia J.
Upite David V.
LandOfFree
Substituted cyclic amine metalloprotease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted cyclic amine metalloprotease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted cyclic amine metalloprotease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3464824